American Oncology Network, Inc. AONC
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 37.79% | 27.00% | 20.01% | -- | -- |
| Total Other Revenue | 15.15% | 13.97% | 11.94% | -- | -- |
| Total Revenue | 37.55% | 26.87% | 19.93% | -- | -- |
| Cost of Revenue | 37.31% | 30.77% | 24.79% | -- | -- |
| Gross Profit | 40.90% | -16.40% | -30.01% | -- | -- |
| SG&A Expenses | 32.04% | 35.88% | 28.30% | -- | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 36.89% | 31.16% | 25.06% | -- | -- |
| Operating Income | 10.20% | -665.39% | -429.04% | -- | -- |
| Income Before Tax | 31.46% | -266.23% | -- | -- | -- |
| Income Tax Expenses | 550.52% | 737.78% | -- | -- | -- |
| Earnings from Continuing Operations | 25.26% | -277.06% | -- | -- | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -24.71% | 257.92% | -- | -- | -- |
| Net Income | 28.31% | -404.41% | -- | -- | -- |
| EBIT | 10.20% | -665.39% | -429.04% | -- | -- |
| EBITDA | 41.12% | -320.40% | -267.59% | -- | -- |
| EPS Basic | -4.57% | -310.35% | -2,277.58% | -- | -- |
| Normalized Basic EPS | -54.59% | 50.39% | 1,050.16% | -- | -- |
| EPS Diluted | -23.36% | -355.23% | -2,488.97% | -- | -- |
| Normalized Diluted EPS | -68.73% | 25.73% | 967.53% | -- | -- |
| Average Basic Shares Outstanding | 107.44% | 96.98% | 145.23% | -- | -- |
| Average Diluted Shares Outstanding | 203.62% | 226.61% | 339.72% | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | 0.80% | -- | -- | -- |